Richard S. Lindahl
2021
Compensation breakdown
| Non-Equity Incentive Plan | $272,550 |
|---|---|
| Option Awards | $588,908 |
| Salary | $577,357 |
| Stock Awards | $750,070 |
| Other | $8,700 |
| Total | $2,197,585 |
Lindahl received $750.1K in stock awards, accounting for 34% of the total pay in 2021.
Lindahl also received $272.6K in non-equity incentive plan, $588.9K in option awards, $577.4K in salary and $8.7K in other compensation.
Rankings
In 2021, Richard S. Lindahl's compensation ranked 5,692nd out of 12,415 executives tracked by ExecPay. In other words, Lindahl earned more than 54.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,692 out of 12,415 | 54th |
Division Manufacturing | 2,417 out of 5,505 | 56th |
Major group Chemicals And Allied Products | 1,049 out of 2,375 | 56th |
Industry group Drugs | 936 out of 2,096 | 55th |
Industry Pharmaceutical Preparations | 673 out of 1,546 | 57th |
Pay ratio
| Richard S. Lindahl's Pay | $2,197,585 |
|---|---|
| Median Employee's Pay | $110,416 |
| Pay Ratio | 20to 1 |
In 2021, the annual total compensation of Richard S. Lindahl was $2,197,585.
The annual total compensation of the median employee at Emergent BioSolutions was $110,416.
The ratio of Richard S. Lindahl's pay to the pay of median employee was therefore 20 to one.
Lindahl's colleagues
We found four more compensation records of executives who worked with Richard S. Lindahl at Emergent BioSolutions in 2021.